ID   KPC3-TRP1
AC   CVCL_A9ZL
DR   Wikidata; Q102114432
RX   PubMed=30381448;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98881; Tyrp1 (Note=With p.Gln512_Val537del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: LSL-KrasG12D:LSL-Trp53R270H:Pdx1-Cre (KPC).
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A9ZK ! KPC3
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 5
//
RX   PubMed=30381448; DOI=10.1158/1535-7163.MCT-18-0679;
RA   Benonisson H., Altintas I., Sluijter M., Verploegen S., Labrijn A.F.,
RA   Schuurhuis D.H., Houtkamp M.A., Verbeek J.S., Schuurman J.,
RA   van Hall T.;
RT   "CD3-bispecific antibody therapy turns solid tumors into inflammatory
RT   sites but does not install protective memory.";
RL   Mol. Cancer Ther. 18:312-322(2019).
//